Leerink Swann Maintains an 'Outperform' on InterMune (ITMN); Lowering PT on Delays in Expected Esbriet Launch

Go back to Leerink Swann Maintains an 'Outperform' on InterMune (ITMN); Lowering PT on Delays in Expected Esbriet Launch